Charleston Oncology
Charleston Oncology is a medical oncology and hematology practice operating as a hospital outpatient department of Bon Secours St. Francis Hospital, with twelve board-certified specialists delivering chemotherapy, immunotherapy, clinical trials, and supportive care across six locations in the South Carolina Lowcountry.
- Company typePrivate
- Founded2019
- HeadquartersCharleston, United States
- Headcount1–10
- GTM typeB2C
- OfferingServices
What Charleston Oncology does
Charleston Oncology is a medical oncology and hematology practice operating as a hospital outpatient department of Bon Secours St. Francis Hospital within the Roper St. Francis Healthcare network. The practice comprises twelve board-certified hematologists and oncologists with over 100 years of combined experience, supplemented by physician assistants, nurse practitioners, and pharmacists, and serves patients across six physical locations in the Charleston, SC Lowcountry (Downtown Charleston, West Ashley, Mt. Pleasant, North Charleston, Summerville, and Walterboro). It diagnoses and treats a broad range of solid tumors and hematologic malignancies — including breast, lung, GI, urologic, skin, head and neck, brain, and bone cancers as well as leukemia, lymphoma, and myeloma — alongside non-malignant blood disorders.
The practice delivers chemotherapy, immunotherapy (monoclonal antibodies, CAR T-cell therapy, immune checkpoint inhibitors, cancer vaccines), targeted therapy, bone marrow transplant, and supportive care modalities including the FDA-approved DigniCap scalp cooling system for chemotherapy-induced hair loss. It participates in clinical trials and holds ASCO QOPI certification, NAPBC breast center accreditation, and American College of Surgeons Commission on Cancer accreditation, while also being selected for the CMS Oncology Care Model. Patient acquisition is driven primarily by referrals from primary care physicians, OBGYNs, and other specialists, supplemented by direct self-referrals via a website/phone intake funnel and a patient portal for appointment requests, bill pay, and lab results.
The business model is professional services billing routed through Roper St. Francis Healthcare, with separate facility and professional charges presented to patients given the hospital outpatient department structure. Revenue is generated from insurance reimbursement (commercial, Medicare, Medicaid) for consultations, chemotherapy, immunotherapy, and other oncology services; the only non-insurance-covered service noted is DigniCap, whose pricing is not publicly disclosed. The practice is not independently owned — it functions as an integrated department of the Roper St. Francis Healthcare system, which provides hospital affiliation, facility support, and centralized billing.
Charleston Oncology firmographics
Firmographics- Name
- Charleston Oncology
- Legal name
- Charleston Oncology
- Website
- https://charlestononcology.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Charleston Oncology is a medical oncology and hematology practice operating as a hospital outpatient department of Bon Secours St. Francis Hospital, with twelve board-certified specialists delivering chemotherapy, immunotherapy, clinical trials, and supportive care across six locations in the South Carolina Lowcountry.
- Ownership category
- akta.pro rank
Charleston Oncology industry classification
Industry- Product category
- Oncology and Hematology Services
- NAICS
- Offices of Physicians (62111), Offices of Physicians (except Mental Health Specialists) (621111)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)
- akta.pro primary industry
- Medical Oncology (HLAKAFAB)
- akta.pro secondary industry
- Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI)
Keywords
Where Charleston Oncology is headquartered
LocationHeadquarters
- HQ city
- Charleston
- HQ country
- United States
- HQ region
- North America
Offices6 records
Markets served
Charleston Oncology business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Supply Chain, Marketing or Sales, Technology or R&D
Revenue model
- Medical Professional Services: Charleston Oncology operates as a hospital outpatient department, billing through Roper St. Francis Healthcare. Revenue is generated through patient consultations, treatments including chemotherapy, immunotherapy, and other oncology services billed to insurance providers including Medicare and Medicaid.
- Facility Services: As a hospital outpatient department of Bon Secours St. Francis Hospital, separate facility charges apply for services including supplies, equipment, and hospital staff. Patients may see separate facility and professional charges on their bills.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | DigniCap Treatment - Not covered by insurance |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels6 records
Charleston Oncology product offering
Product offeringCore offering
Charleston Oncology is a medical oncology and hematology practice that diagnoses and treats all types of cancer and blood disorders. Services are delivered by twelve subspecialized hematologists and oncologists across six Lowcountry locations, and include chemotherapy, immunotherapy, targeted therapy, bone marrow transplant, DigniCap scalp cooling, and clinical trial access. The practice operates as a hospital outpatient department of Bon Secours St. Francis Hospital within the Roper St. Francis Healthcare network.
Product overview
Charleston Oncology is a medical oncology and hematology practice operated by Bon Secours St. Francis Hospital as part of the Roper St. Francis Healthcare network. The practice offers a comprehensive suite of cancer care services centered around twelve hematologists and oncologists with over 100 years of combined experience. Core offerings include medical oncology, hematology, immunotherapy, the FDA-approved DigniCap scalp cooling system, clinical trials participation, and a patient portal for appointment management and accessing lab results. Treatment modalities encompass chemotherapy, radiation therapy, targeted therapy, bone marrow transplant, and adoptive cell therapies including CAR T-cell. The practice operates six locations across South Carolina's Lowcountry region.
Differentiator
Problem solved
Functional benefit
Products and services
- Medical Oncology and Hematology Services Comprehensive diagnosis and treatment of all types of cancer and blood disorders delivered by twelve subspecialized hematologists and oncologists with over 100 years of combined experience across six South Carolina Lowcountry locations. Includes chemotherapy, targeted therapy, bone marrow transplant, and supportive care.
- Immunotherapy Biologic therapy that harnesses the patient's own immune system to fight cancer, including monoclonal antibodies, adoptive cell transfer therapy (CAR T-cell), immune checkpoint inhibitors, and cancer vaccines.
- DigniCap Scalp Cooling System FDA-approved scalp cooling device that reduces chemotherapy-induced hair loss by cooling the scalp to decrease blood flow, preventing chemotherapy from reaching hair cells. Indicated for women with breast cancer; not covered by insurance.
- Blood Disorder Treatment Treatment for various blood disorders including blood cancers (lymphoma, leukemia, multiple myeloma), anemia, thrombocytopenia, and plasma-related disorders through iron infusions, blood transfusions, and targeted therapies.
- Clinical Trials Program Participation in clinical trials offering patients access to cutting-edge treatments and emerging cancer therapies not yet widely available.
Quantifiable outcome
- Seven out of 10 patients with early-stage breast cancer kept at least 50% of their hair using DigniCap system
- +2 more outcomes
Companies that use Charleston Oncology
Customer profileNamed customers12 records
Segments5 records
Ideal customer profiles2 records
Charleston Oncology technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Charleston Oncology partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and minor.
- Bon Secours St. Francis Hospital / Roper St. Francis HealthcarecoreCharleston Oncology is operated by Bon Secours St. Francis Hospital as an outpatient department, part of the Roper St. Francis Healthcare cancer services network across the Lowcountry. Bills come from Roper St. Francis Healthcare. This partnership provides hospital affiliation, facility support, and integration with the broader healthcare system.
- Centers for Medicare & Medicaid Services (CMS)minorSelected as one of nearly 200 physician group practices to participate in a care delivery model that supports and encourages higher quality, more coordinated cancer care. This is a federal government initiative program participation.
- DigniCap (Cooling Technology)coreCharleston Oncology has the DigniCap System, FDA approved for women with breast cancer. The DigniCap system is the first and only scalp cooling device to complete rigorous FDA clinical trials. This partnership provides advanced technology for chemotherapy-induced hair loss prevention.
Scale indicators4 records
Recent moves7 records
Expansion highlights4 records
Charleston Oncology competitors and assessment
Company assessmentBroad incumbents
- Tennessee Oncology: Multi-site community oncology and hematology practice serving Tennessee with subspecialized physicians, infusion, and clinical research; comparable scale, structure, and service mix as Charleston Oncology.
- Florida Cancer Specialists & Research Institute: Large community oncology practice with site-based delivery across Florida offering chemotherapy, immunotherapy, and clinical trials; comparable in operating model as a high-volume, multi-location private oncology group with research programs.
- Texas Oncology: Large multi-state network of medical oncologists providing subspecialized cancer care across Texas; comparable as a physician-led, community-based oncology practice model with multiple locations and clinical trial participation.
Direct peers
- Compass Oncology: Multi-specialty community oncology group in Oregon/SW Washington with subspecialized medical oncologists, infusion, imaging, and clinical trials; comparable as a physician-owned regional oncology practice operating multiple sites.
- Virginia Cancer Specialists: Community-based oncology practice with multiple Northern Virginia sites delivering medical oncology, hematology, and clinical trials; closely comparable in practice model and subspecialization approach.
- Georgia Cancer Specialists: Private medical oncology and hematology practice with multiple Atlanta-area locations offering subspecialized care, clinical trials, and infusion services; direct peer in scope, structure, and Southeast US positioning.
- Northwest Medical Specialties: Independent community oncology and hematology practice in the Pacific Northwest providing medical oncology, infusion, and research services; similar as a private, multi-physician subspecialized oncology practice.
- New York Oncology Hematology: Multi-location community hematology/oncology practice in Upstate New York offering diagnosis, treatment, and clinical trials; analogous in practice structure, subspecialization, and site-based delivery model.
Regional players
- Medical University of South Carolina Hollings Cancer Center: NCI-designated academic cancer center in Charleston providing medical oncology, radiation, surgery, and clinical trials; competes with Charleston Oncology for complex cancer cases in the same Lowcountry geography.
Others
- Bon Secours Mercy Health: Parent-affiliated multi-state Catholic health system that operates Charleston Oncology as an HOPD; relevant for understanding the structural, billing, and strategic context the practice operates within.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Charleston Oncology social profiles
Digital presenceCharleston Oncology financial estimates
Financial estimateRevenue estimate
Valuation estimate
Charleston Oncology leadership team
Management profileNumber of profiles
Profiles13 records
Charleston Oncology funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Charleston Oncology M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Charleston Oncology
What does Charleston Oncology do?
Charleston Oncology is a medical oncology and hematology practice that diagnoses and treats all types of cancer and blood disorders. Services are delivered by twelve subspecialized hematologists and oncologists across six Lowcountry locations, and include chemotherapy, immunotherapy, targeted therapy, bone marrow transplant, DigniCap scalp cooling, and clinical trial access. The practice operates as a hospital outpatient department of Bon Secours St. Francis Hospital within the Roper St. Francis Healthcare network.
Is Charleston Oncology a public or private company?
Charleston Oncology is a private company. It is classified as corporate owned and is currently operating.
When was Charleston Oncology founded?
Charleston Oncology was founded in 2019. It employs 1 to 10 people.
Where is Charleston Oncology based?
Charleston Oncology is headquartered in Charleston, United States, in the North America region.
How does Charleston Oncology make money?
Two revenue lines are on record. Medical Professional Services are the primary driver. The others are facility Services.
Who are Charleston Oncology's main competitors?
Broad incumbents on record are Tennessee Oncology, Florida Cancer Specialists & Research Institute and Texas Oncology. Direct peers are Compass Oncology, Virginia Cancer Specialists, Georgia Cancer Specialists, Northwest Medical Specialties and New York Oncology Hematology. Medical University of South Carolina Hollings Cancer Center is listed as a regional player. Bon Secours Mercy Health is listed as an others.
Does Charleston Oncology have an API?
No public API is recorded for Charleston Oncology.
What industry is Charleston Oncology in?
Charleston Oncology's product category is Oncology and Hematology Services. Its primary akta.pro industry code is HLAKAFAB, Medical Oncology, with a secondary code of HLAFABAI, Ambulatory Oncology Centers (Outpatient Chemo/Radiation). Its NAICS code is 62111 and its SIC code is 8011.